Get started
Author

Eduardo Asín‐Prieto

Observed names: E. Asin-Prieto, E. Asín-Prieto, Eduardo Asin-Prieto, Eduardo Asín, Eduardo Asín-Prieto
Institution: PharmaMar (Spain)
Observed institutions: Inserm, University of the Basque Country, Université de Poitiers, University of Florida, Navarre Institute of Health Research, PharmaMar (Spain), Universidad de Navarra
ORCID: 0000-0001-9122-6758
Observed ORCID: 0000-0001-9122-6758
OpenAlex ID: A5007573955
Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents
2015 · Eduardo Asín-Prieto, Alicia Rodríguez-Gascón, et al. · Journal of Infection and Chemotherapy · 272
Hyaluronic acid coating of gold nanoparticles for intraocular drug delivery: Evaluation of the surface properties and effect on their distribution
2020 · P.S. Apaolaza, M. Busch, et al. · Experimental Eye Research · 105
Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis
2013 · E. Asin-Prieto, A. Rodriguez-Gascon, et al. · Journal of Antimicrobial Chemotherapy · 71
Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation
2020 · Amaia Soraluce, Helena Barrasa, et al. · Pharmaceutics · 42
PDF
Population pharmacokinetics of daptomycin in critically ill patients
2018 · A. Soraluce, E. Asín-Prieto, et al. · International Journal of Antimicrobial Agents · 42
Comparison of antimicrobial pharmacokinetic/pharmacodynamic breakpoints with EUCAST and CLSI clinical breakpoints for Gram-positive bacteria
2012 · Eduardo Asín, Arantxazu Isla, et al. · International Journal of Antimicrobial Agents · 38
Zein Nanoparticles Improve the Oral Bioavailability of Curcumin in Wistar Rats
2021 · Ana Brotons-Canto, Carlos J. González-Navarro, et al. · Pharmaceutics · 37
PDF
Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function
2021 · Idoia Bilbao-Meseguer, Helena Barrasa, et al. · Pharmaceutics · 31
PDF
Population pharmacokinetic models for cefuroxime and metronidazole used in combination as prophylactic agents in colorectal surgery: Model-based evaluation of standard dosing regimens
2015 · Eduardo Asín-Prieto, Amaia Soraluce, et al. · International Journal of Antimicrobial Agents · 29
A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis
2019 · J. W. S. Cattrall, E. Asín-Prieto, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 25
PDF
Predicting Pediatric Age-Matched Weight and Body Mass Index
2014 · Sherwin K. B. Sy, Eduardo Asin-Prieto, et al. · The AAPS Journal · 19
PDF
Meropenem dosing requirements against Enterobacteriaceae in critically ill patients: influence of renal function, geographical area and presence of extended-spectrum β-lactamases
2016 · A. Isla, A. Canut, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 18
Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study
2022 · Idoia Bilbao-Meseguer, Helena Barrasa, et al. · Journal of Intensive Care · 16
PDF
Effect of reducing the paediatric stavudine dose by half: A physiologically-based pharmacokinetic model
2015 · Sherwin K.B. Sy, Ruben Malmberg, et al. · International Journal of Antimicrobial Agents · 15
PDF
Predicting circulating biomarker response and its impact on the survival of advanced melanoma patients treated with adjuvant therapy
2020 · Itziar Irurzun-Arana, Eduardo Asín-Prieto, et al. · Scientific Reports · 12
PDF
A Quantitative Systems Pharmacology Model for the Key Interleukins Involved in Crohn's Disease
2019 · Violeta Balbas-Martinez, Eduardo Asin-Prieto, et al. · Journal of Pharmacology and Experimental Therapeutics · 12
A quantitative systems pharmacology model for acute viral hepatitis B
2021 · Eduardo Asín-Prieto, Zinnia P. Parra-Guillen, et al. · Computational and Structural Biotechnology Journal · 7
Colo-Pro: a pilot randomised controlled trial to compare standard bolus-dosed cefuroxime prophylaxis to bolus-continuous infusion–dosed cefuroxime prophylaxis for the prevention of infections after colorectal surgery
2018 · Andrew Kirby, Eduardo Asín-Prieto, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 7
PDF
The Long Neglected Player: Modeling Tumor Uptake to Guide Optimal Dosing
2018 · Leire Ruiz-Cerdá, Eduardo Asín-Prieto, et al. · Clinical Cancer Research · 7
A model-based head-to-head comparison of single-agent lurbinectedin in the pivotal ATLANTIS Study
2023 · Salvador Fudio, Laura Pérez-Ramos, et al. · Frontiers in Oncology · 5
Immune network for viral hepatitis B: Topological representation
2019 · Eduardo Asín-Prieto, Zinnia P. Parra-Guillen, et al. · European Journal of Pharmaceutical Sciences · 4
Description and Modeling of Relevant Demographic and Laboratory Variables in a Large Oncology Cohort to Generate Virtual Populations
2024 · Laura Pérez-Ramos, Laura Ibarra-Gómez, et al. · Pharmaceutics · 2
PDF
CYP3A Genotype Is Associated With Variability in the Exposure and Clearance of the Novel Oncogenic Transcription Inhibitor Lurbinectedin
2025 · Rubin Lubomirov, Laura Pérez‐Ramos, et al. · Clinical and Translational Science · 1
Pharmacokinetic/pharmacodynamic analysis to optimize antibacterial therapy: application on breakpoint setting and dosing evaluation in critically ill patients and in surgical prophylaxis
2015 · Eduardo Asín-Prieto · Dialnet (Universidad de la Rioja)
Works count: 24
Citation count: 817
H-index: 14
I10-index: 16
Year
Topic
Type